文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

基于铁蛋白的促性腺激素释放激素纳米颗粒疫苗的制备及免疫原性评估

Preparation and Immunogenicity Evaluation of a Ferritin-Based GnRH Nanoparticle Vaccine.

作者信息

Xu Ying, Zhao Weihao, Zhu Yuhan, Sun Bo, Wu Congmei, Yin Yuhe

机构信息

College of Chemistry and Life Sciences, Changchun University of Technology, Changchun 130012, China.

School of Life Sciences, Jilin University, Changchun 130012, China.

出版信息

Vaccines (Basel). 2025 Jul 23;13(8):781. doi: 10.3390/vaccines13080781.


DOI:10.3390/vaccines13080781
PMID:40872868
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12389962/
Abstract

: Research on the immunocastration vaccine is of great significance for animal management. In this study, the gonadotropin-releasing hormone (GnRH) ferritin nanoparticle vaccine was constructed using Spy Catcher-Spy Tag (SC-ST) as a delivery system; : The Spy Catcher was constructed to fuse with the expression vector pET-30a-SF of ferritin nanoparticles. Two polypeptides, STG1: Spy Tag-GnRH I-PADRE and STG2: Spy Tag-GnRH I-GnRH II, coupled to SF in vitro to form two nanoparticles, were designed and synthesized to detect castration effects in mice. We mixed them with the adjuvant MONTANIDE ISA 206 VG to explore the adjuvant's effect on immunogenicity; : All immunized groups produced anti-GnRH specific antibodies after the second immunization, which was significantly higher in the immunized group and the combined adjuvant group than in the control group, and the immune response could still be detected at the 12th week. The concentrations of testosterone, follicle-stimulating hormone, and luteinizing hormone in serum were significantly decreased. The number of sperm in the epididymis of mice in each immune group was significantly reduced, and the rate of sperm deformity was high; : The two ferritin-based GnRH nanoparticles developed in this study can significantly cause testicular atrophy, decreased gonadal hormone concentration, decreased sperm count, and increased deformity rate in male mice. These findings provide experimental evidence supporting their potential application in animal immunocastration.

摘要

免疫去势疫苗的研究对动物管理具有重要意义。在本研究中,以Spy Catcher-Spy Tag(SC-ST)作为递送系统构建促性腺激素释放激素(GnRH)铁蛋白纳米颗粒疫苗;将Spy Catcher构建为与铁蛋白纳米颗粒的表达载体pET-30a-SF融合。设计并合成了两种在体外与SF偶联形成两种纳米颗粒的多肽STG1:Spy Tag-GnRH I-PADRE和STG2:Spy Tag-GnRH I-GnRH II,用于检测小鼠的去势效果。将它们与佐剂MONTANIDE ISA 206 VG混合,以探究佐剂对免疫原性的影响;所有免疫组在第二次免疫后均产生了抗GnRH特异性抗体,免疫组和联合佐剂组的抗体水平显著高于对照组,且在第12周仍可检测到免疫反应。血清中睾酮、促卵泡激素和促黄体生成素的浓度显著降低。各免疫组小鼠附睾中的精子数量显著减少,精子畸形率较高;本研究开发的两种基于铁蛋白的GnRH纳米颗粒可显著导致雄性小鼠睾丸萎缩、性腺激素浓度降低、精子数量减少和畸形率增加。这些发现为它们在动物免疫去势中的潜在应用提供了实验证据。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d11a/12389962/41e87adffdd3/vaccines-13-00781-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d11a/12389962/4b1fa6148a70/vaccines-13-00781-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d11a/12389962/fe4827dbb5e3/vaccines-13-00781-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d11a/12389962/6a7068cb9798/vaccines-13-00781-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d11a/12389962/68f8e94c1a76/vaccines-13-00781-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d11a/12389962/63bba2d8e0fe/vaccines-13-00781-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d11a/12389962/d37af6dbea5c/vaccines-13-00781-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d11a/12389962/7afabd3f6111/vaccines-13-00781-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d11a/12389962/93d708504c0d/vaccines-13-00781-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d11a/12389962/31b10fcd57cb/vaccines-13-00781-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d11a/12389962/edee08146347/vaccines-13-00781-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d11a/12389962/41e87adffdd3/vaccines-13-00781-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d11a/12389962/4b1fa6148a70/vaccines-13-00781-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d11a/12389962/fe4827dbb5e3/vaccines-13-00781-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d11a/12389962/6a7068cb9798/vaccines-13-00781-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d11a/12389962/68f8e94c1a76/vaccines-13-00781-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d11a/12389962/63bba2d8e0fe/vaccines-13-00781-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d11a/12389962/d37af6dbea5c/vaccines-13-00781-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d11a/12389962/7afabd3f6111/vaccines-13-00781-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d11a/12389962/93d708504c0d/vaccines-13-00781-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d11a/12389962/31b10fcd57cb/vaccines-13-00781-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d11a/12389962/edee08146347/vaccines-13-00781-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d11a/12389962/41e87adffdd3/vaccines-13-00781-g011.jpg

相似文献

[1]
Preparation and Immunogenicity Evaluation of a Ferritin-Based GnRH Nanoparticle Vaccine.

Vaccines (Basel). 2025-7-23

[2]
Prescription of Controlled Substances: Benefits and Risks

2025-1

[3]
Gonadotropin-releasing hormone agonist versus HCG for oocyte triggering in antagonist-assisted reproductive technology.

Cochrane Database Syst Rev. 2014-10-31

[4]
Preparation of two kinds of immunocastration vaccines and their immune effects on male goats.

Anim Biosci. 2025-7

[5]
Gonadotropin-releasing hormone (GnRH) analogues for premenstrual syndrome (PMS).

Cochrane Database Syst Rev. 2025-6-10

[6]
Gonadotrophin-releasing hormone antagonists for assisted reproductive technology.

Cochrane Database Syst Rev. 2016-4-29

[7]
Active immunization with a novel recombinant GnRH vaccine inhibits reproductive function in male goats.

Domest Anim Endocrinol. 2025-4

[8]
Interventions for fertility preservation in women with cancer undergoing chemotherapy.

Cochrane Database Syst Rev. 2025-6-19

[9]
Immunogenicity and seroefficacy of pneumococcal conjugate vaccines: a systematic review and network meta-analysis.

Health Technol Assess. 2024-7

[10]
SHR7280, an oral gonadotropin-releasing hormone antagonist, for the prevention of premature luteinizing hormone surge in controlled ovarian hyperstimulation: a dose-finding, phase 2 trial.

Hum Reprod. 2025-7-1

本文引用的文献

[1]
Structure-guided design and evaluation of CRM197-scaffolded vaccine targeting GnRH for animal immunocastration.

Appl Microbiol Biotechnol. 2024-11-9

[2]
Ferritin Vaccine Platform for Animal and Zoonotic Viruses.

Vaccines (Basel). 2024-9-27

[3]
Endogenous capsid-forming protein ARC for self-assembling nanoparticle vaccines.

J Nanobiotechnology. 2024-8-27

[4]
Vertasile ferritin nanocages: Applications in detection and bioimaging.

Biosens Bioelectron. 2024-10-15

[5]
A ferritin-based nanoparticle displaying a neutralizing epitope for foot-and-mouth disease virus (FMDV) confers partial protection in guinea pigs.

BMC Vet Res. 2024-7-6

[6]
Development of a PCSK9-targeted nanoparticle vaccine to effectively decrease the hypercholesterolemia.

Cell Rep Med. 2024-6-18

[7]
The association of testosterone with sarcopenia and frailty in chronic liver disease.

Eur J Clin Invest. 2024-2

[8]
A SARS-CoV-2 nanoparticle vaccine based on chemical conjugation of loxoribine and SpyCatcher/SpyTag.

Int J Biol Macromol. 2023-12-31

[9]
Ferritin-based nanomedicine for disease treatment.

Med Rev (2021). 2023-3-10

[10]
Effect of Testosterone Replacement Therapy on Sexual Function and Hypogonadal Symptoms in Men with Hypogonadism.

J Clin Endocrinol Metab. 2024-1-18

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索